Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Metformin vs Salicylic Acid Peeling in Acne Vulgaris
NCT05536193Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Sep 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of metformin 1% gel in acne vulgaris, sponsored by Assiut University. Primary endpoints: Efficacy of the medications at 12 weeks and Serum concentration of insulin-like growth factor 1 (IGF-1) at 12 weeks. Status: unknown.
02
Drugs
metformin 1% gel
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT05536193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05536193.